Evidence map›Paper›PMID 27089154›Full record

Trial reportJournal of dual diagnosis2016

Patterns of Substance Use During Cognitive Enhancement Therapy: An 18-Month Randomized Feasibility Study.

Shaun M Eack, Susan S Hogarty, Srihari S Bangalore, Matcheri S Keshavan, Jack R Cornelius

Registry-linked trialOpen access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of dual diagnosis, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01292577 (Adapted Cognitive/Affective Remediation for Cannabis Misuse in Schizophrenia), which is not on this map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
6.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01292577 phase1 / phase2completednot on this map

Adapted Cognitive/Affective Remediation for Cannabis Misuse in Schizophrenia

TypeinterventionalSponsorUniversity of PittsburghRan2010 to 2014Enrolled33ConditionsSchizophrenia, Schizoaffective DisorderArmsCET/PT, Treatment as Usual
3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Shaun M Eacka School of Social Work, University of Pittsburgh , Pittsburgh , Pennsylvania , USA.
Susan S Hogartyb Department of Psychiatry , University of Pittsburgh School of Medicine , Pittsburgh , Pennsylvania , USA.
Srihari S Bangaloreb Department of Psychiatry , University of Pittsburgh School of Medicine , Pittsburgh , Pennsylvania , USA.
Matcheri S Keshavanc Department of Psychiatry , Harvard Medical School , Boston , Massachussetts , USA.
Jack R Corneliusb Department of Psychiatry , University of Pittsburgh School of Medicine , Pittsburgh , Pennsylvania , USA.
University of Pittsburgh · USHarvard University · US

Funding

University of Pittsburgh Clinical and Translational Science InstitutionKL2RR024154 · NCRR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI REIS, STEVEN E · 2006 to 2011
$22.2M
Social-Cognitive Rehabilitation and Brain Function in Early SchizophreniaK23MH095783 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI EACK, SHAUN M · 2012 to 2015
$629k
Adapted Cognitive/Affective Remediation for Cannabis Misuse in SchizophreniaR21DA030763 · NIDA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI EACK, SHAUN M · 2010 to 2011
$411k
NCRR NIH HHS K12 RR024154NCRR NIH HHS KL2 RR024154NCRR NIH HHS RR-24154NIDA NIH HHS DA-30763NIDA NIH HHS R21 DA030763NIMH NIH HHS K23 MH095783NIMH NIH HHS MH-95783
6 · The paper itself

Abstract

objectiveSubstance use problems are common among people with schizophrenia, as are significant cognitive impairments. Because of potential shared neurobiological pathways, it is possible that cognitive remediation interventions may be associated with improvements in both substance use and cognition. This study examined the impact of cognitive remediation on alcohol and cannabis use and the cognitive correlates of changes in substance use among outpatients with schizophrenia.

methodsIndividuals with schizophrenia who were receiving outpatient services at a psychiatric clinic and had moderate or higher addiction severity scores (N = 31) were randomized to 18 months of cognitive enhancement therapy (n = 22) or usual care (n = 9). Cognitive enhancement therapy is a cognitive remediation approach that integrates computer-based training in attention, memory, and problem solving with a group-based social cognition curriculum. Usual care was provided to all participants and consisted of routine psychiatric care. Primary outcomes included days of alcohol and cannabis use, assessed with the Timeline Followback method every six months and modeled using penalized quasi-likelihood growth curves.

resultsParticipants were on average 38.23 (SD = 13.44) years of age, had been ill for 14.19 (SD = 11.28) years, and were mostly male (n = 22, 71%), and about half were Caucasian (n = 16, 52%). Temporal patterns of substance use days were highly variable and followed nonlinear trajectories. Intent-to-treat analyses indicated that, compared to patients only receiving usual care, those receiving cognitive enhancement therapy were significantly less likely to use alcohol (OR = .22; 95% CI: .05, .90; p = .036), but not cannabis (OR = 1.89; 95% CI: .02, 142.99; p = .774) over time, and they reduced their alcohol use at significantly accelerated rates (OR = 1.02; 95% CI: 1.01, 1.03; p = .003). Changes in cognition were variably associated with substance use outcomes, although improvements in visual learning and reasoning and problem solving were both consistently related to reduced alcohol and cannabis use.

conclusionsCognitive remediation may be effective for improving some substance use problems in schizophrenia. Visual learning and problem-solving deficits may be particularly important targets of such interventions, given their association with reduced alcohol and cannabis use. This study is registered at clinicaltrials.gov under #NCT01292577.

Indexed as

AdultCognitionCognitive Behavioral TherapyDiagnosis, Dual (Psychiatry)Feasibility StudiesFemaleHumansMaleNonlinear DynamicsOutpatientsPsychotic DisordersSchizophreniaSchizophrenic PsychologySeverity of Illness IndexSubstance-Related DisordersTherapy, Computer-AssistedCognitive remediationschizophreniasubstance use disorder

Identifiers

PMID27089154
PMCPMC4837677
OpenAlexW2336468673

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.